Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jul 19;14(7):e243829.
doi: 10.1136/bcr-2021-243829.

Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses

Affiliations
Case Reports

Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses

Abigail Burrows et al. BMJ Case Rep. .

Abstract

A 61-year-old man presented to the ENT emergency clinic with a history of unilateral facial nerve palsy occurring shortly after each dose of the Pfizer-BioNTech COVID-19 vaccine. The first episode developed 5 hours after administration of the first dose and the second 2 days after administration of the second dose. Investigations at initial presentation to the emergency department were unremarkable, and the patient was diagnosed with Bell's palsy on both occasions. We describe the first case of Bell's palsy occurring after each dose of any UK-approved COVID-19 vaccine. Single episodes of unilateral facial nerve palsies have been reported in clinical trials and in subsequent case reports. There has been no evidence, however, of an episode after each dose. We also describe the earliest onset of symptoms from timing of administration of the vaccine, further suggesting the Bell's palsy was associated with the vaccine.

Keywords: COVID-19; cranial nerves; otolaryngology / ENT; safety; vaccination/immunisation.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Similar articles

Cited by

References

    1. European Medicines Agency. COVID-19 vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets, 2021. Available: https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-benefits-... [Accessed 8 Apr 2021].
    1. Cirillo N. Reported orofacial adverse effects of COVID-19 vaccines: the knowns and the unknowns. J Oral Pathol Med 2021;50:424–7. 10.1111/jop.13165 - DOI - PMC - PubMed
    1. Public Assessment Report - COVID-19 Vaccine Moderna, 0.20 mg/mL dispersion for injection, 2021. Available: https://assets.publishing.service.gov.uk/government/uploads/system/uploa... [Accessed 8 Apr 2021].
    1. MHRA . Public Assessment Report COVID-19 Vaccine AstraZeneca, solution for injection in multidose container COVID-19 Vaccine (ChAdOx1-S [recombinant]), 2021. Available: https://assets.publishing.service.gov.uk/government/uploads/system/uploa... [Accessed 8 April 2021].
    1. GOV.UK . Information for UK recipients on Pfizer/BioNTech COVID-19 vaccine [Internet], 2021. Available: https://www.gov.uk/government/publications/regulatory-approval-of-pfizer... [Accessed 8 Apr 2021].

Publication types

Substances